Callori Fred
SEC insider (Form 3/4/5 filer). CIK 0001843393. Director at LeonaBio, Inc. (LONA) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in BOTHELL, WA.
Companies Callori Fred has filed insider reports for
- LeonaBio, Inc. (LONA): Director
- Astria Therapeutics, Inc. (ATXS): Director
Callori Fred
CIK: 0001843393
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 23, 2026LONA
LeonaBio, Inc.
AwardDirectStock Option (Right to Buy)
2.3K shares- - May 5, 2026LONA
LeonaBio, Inc.
AwardDirectStock Option (Right to Buy)
56K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
8.3K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
14.1K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
14.1K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
26.6K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
14.2K shares- - Jun 11, 2025ATXS
Astria Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
26.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 |  LONA LeonaBio, Inc. | Award Stock Option (Right to Buy) | 2,333 | - | - | Direct |
| May 5, 2026 | LONA LeonaBio, Inc. | Award Stock Option (Right to Buy) | 56,000 | - | - | Direct |
| Jan 23, 2026 |  ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 8,333 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 14,100 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 14,100 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 26,550 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 14,166 | - | - | Direct |
| Jun 11, 2025 | ATXS Astria Therapeutics, Inc. | Award Stock Option (Right to Buy) | 26,550 | - | - | Direct |
1-8 of 8 transactions